PROCEPT BioRobotics (PRCT) Non-Current Deffered Revenue (2023)

PROCEPT BioRobotics' (PRCT) quarterly Non-Current Deffered Revenue came in at $517000.0 in Q3 2023, up 44.82% on a QoQ basis from $357000.0 in Q2 2023.

PROCEPT BioRobotics (PRCT) Non-Current Deffered Revenue (2023) Analysis & Trends

PROCEPT BioRobotics (PRCT) has 1 years of Non-Current Deffered Revenue data on file, last reported at $517000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 512.79 Mn
10 PROCEPT BioRobotics 1.00 Bn 757.43 Mn 53.95 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 517,000.00
Jun 30, 2023 357,000.00